NCT07217301
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07217301
Title IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed (MarsLight-11)
Acronym MarsLight-11
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Fortvita Biologics (USA)Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Health Services RECRUITING Fountain Valley California 92708 United States Details
BRCR Global RECRUITING Tamarac Florida 33321 United States Details
Shanghai Chest Hospital RECRUITING Shanghai Shanghai Municipality 200030 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field